Form 4: Teladoc Health Director Smith Increases Stake with $28,312 Purchase

Director Mark Douglas Smith recently purchased 4,000 shares of Teladoc Health (TDOC) at $7.078 per share, increasing his holdings to 8,355 shares.

Summary

• On August 15, 2024, Mark Douglas Smith, a director of Teladoc Health, Inc. (TDOC), purchased 4,000 shares of common stock.
• The purchase price was $7.078 per share.
• Following the transaction, Smith directly owns 8,355 shares of Teladoc Health.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive due to the director's purchase, suggesting confidence. However, it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored as an indicator of management's sentiment about the company's prospects. It's a common practice for directors and officers to buy or sell shares of their own company, and these transactions are subject to regulatory oversight to prevent insider trading.

Comparison to Industry Standards

• Comparing this insider purchase to similar transactions in the telehealth industry is difficult without broader data.
• However, insider buying is generally viewed positively, especially when compared to insider selling.
• It would be useful to compare Smith's trading activity to that of other directors or officers at Teladoc Health and its competitors like Amwell or Telus Health to gauge the relative strength of this signal.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates